| Accession Number | 0001022079-26-000053 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 8, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Clinical Solutions | Common Stock | โ | Jun 4, 2026 | Exercise/Conversion | 3,320 | $127.72 | $424,047.00 | 16,830 | Direct | โ | View Details | |
SVP, Clinical Solutions | Common Stock | โ | Jun 4, 2026 | Exercise/Conversion | 4,827 | $121.81 | $587,952.73 | 21,657 | Direct | โ | View Details | |
SVP, Clinical Solutions | Common Stock | โ | Jun 4, 2026 | Sale | 8,147 | $200.00 | $1,629,400.00 | 13,510 | Direct | โ | View Details | |
SVP, Clinical Solutions | Non-Qualifed Stock Option (right to buy) | Derivative | Jun 4, 2026 | Exercise/Conversion | 3,320 | $127.72 | $424,047.00 | 0 | Direct | โ | View Details | |
SVP, Clinical Solutions | Non-Qualifed Stock Option (right to buy) | Derivative | Jun 4, 2026 | Exercise/Conversion | 4,827 | $121.81 | $587,952.73 | 0 | Direct | โ | View Details |